Viewing Study NCT06930794


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2025-12-31 @ 7:15 PM
Study NCT ID: NCT06930794
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2025-02-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Vebreltinib and Platinum-Containing Double Agents in Subjects With MET Amplification.
Sponsor: Beijing Pearl Biotechnology Limited Liability Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module